Risk Mitigation Strategies for High-Performance Horses
Christa Lesté-Lasserre, MA
May 2, 2017
The OIE has described management “pillars” to keep most diseases at bay for high-health, high-performance horses.
The OIE has described management “pillars” to keep most diseases at bay for high-health, high-performance horses.
Xylazine, detomidine, and romifidine appear to have few effects on lameness exam results when used without butorphanol.
The study evaluated the effectiveness of ivermectin and fenbendazole, as well as owners’ deworming practices.
Rutgers researchers have gained a better understanding of how horses’ bodies change as they age. Here’s what we know.
Dr. David Horohov, UK Gluck Equine Research Center director, gives a overview of vaccines and explains their importance.
Weight gain is a common sign of EMS. But what other indicators should horse owners watch for?
The mainstays of biosecurity still center around good hygiene, diagnostics, quarantine, isolation, and traffic control.
This could encourage the use of targeted deworming programs to help reduce parasite resistance, scientists said.
Sarah Elzinga, MS, is studying inflammation and insulin dysregulation in the horse.
Veterinary officials encouraged owners to vaccinate against rabies, Eastern equine encephalitis, and West Nile virus.
Overweight mares often produce heavier foals, which studies have shown are at-risk for musculoskeletal disorders.
Anthelmintic resistance occurs worldwide. With only three drug classes to choose from, are we running out of options?
The UHVRC has delivered more than 25,000 doses of core vaccines to protect horses in need since its inception in 2009.
Dr. Kevin Hankins explains why senior horses are in a category of their own for vaccinations and care.
In the past, researchers developed new classes of antiparasitic compounds every 10 years or so. But what works today?
A panel believes keys include additional out-of-competition testing, investigators, and research.
Stay on top of the most recent Horse Health news with
